The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased Omnicare Inc. stock prior to May 21, 2015.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Omnicare Inc. (NYSE: OCR) to CVS Health Corp. (NYSE: CVS) for $98 per share in cash. To learn more about the investigation and your rights, go to:

HTTP://ZLK.9NL.COM/OMNICARE-OCR

or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Levi & Korsinsky, LLPJoseph Levi, Esq.Eduard Korsinsky, Esq.Tel: 212-363-7500Toll Free: 877-363-5972Fax: 212-363-7171www.zlk.com

Omnicare (NYSE:OCR)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025 Plus de graphiques de la Bourse Omnicare
Omnicare (NYSE:OCR)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025 Plus de graphiques de la Bourse Omnicare